Skip to the page

Data / Form D filings / Arthrosi Therapeutics, Inc.

Arthrosi Therapeutics, Inc.: Form D filings

Arthrosi Therapeutics, Inc., a pharmaceuticals company in Laguna Hills, CA, filed 8 Form D notices with the SEC between 2018 and 2025. The latest, on June 24, 2025, reports $60.9 million sold of a $153.1 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
23052 ALCALDE DRIVE, SUITE A, Laguna Hills, CA, 92653
Phone
(714) 813-0709
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1741062

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 24, 2025New notice$153,110,000$60,869,972$92,240,02813Jun 6, 2025sec.gov
Jan 26, 2024New notice$75,000,000$7,000,000$68,000,0001Sep 5, 2023sec.gov
Mar 3, 2023New notice$20,000,000$15,000,000$5,000,0002Feb 7, 2023sec.gov
Nov 15, 2021New notice$30,000,000$26,000,000$4,000,0002Aug 16, 2021sec.gov
Nov 15, 2021New notice$220,000$220,0001Aug 2, 2021sec.gov
Jun 3, 2020New notice$20,000,000$8,500,000$11,500,0003May 20, 2020sec.gov
Jan 30, 2019New notice$11,000,000$11,000,0003Oct 29, 2018sec.gov
Jun 29, 2018New notice$4,282,548$4,282,5483Jan 24, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Zhang MingyuanDirector
Chaohua YuanDirector
Xiaodong WangDirector
John LeamanDirector
Hanxiong LiDirector
Thomas HuangDirector
Xin XieDirector
Litain YehExecutive Officer, Director, Promoter
Shunqi YanExecutive Officer, Director, Promoter

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Jun 23, 2025 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Arthrosi Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.